SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Eva Perón
| Patient | Eva Perón |
|---|
| Date of birth | 1994-05-07 |
|---|
| Identifiers | MRN HR-ML025-SYN; SSN (made up) 000-25-7316 |
|---|
| Document date | 2026-03-27 |
|---|
| Author | Lucía Barragán, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Burning on passing urine and cloudy urine for two days, in the third week of chemoradiation. [S]
History of Present Illness
Ms. Perón called the clinic and was seen the same day, with the visit in Spanish. She is in the third week of pelvic radiation and had her third weekly cisplatin dose four days ago. Since radiation began she has needed to pass urine a little more often, as she was told to expect. For two days she has had new burning, strong urgency, and cloudy, strong-smelling urine. She has had no fever, chills, back or side pain, or vomiting, and no blood in the urine. Her bowels are looser, twice a day, controlled with loperamide; nausea after cisplatin settles with ondansetron. The vaginal bleeding has nearly stopped. She is tired but still working half days. She has been coping, and the social worker has seen her once during treatment. [S]
| Element | Detail |
|---|
| Onset | Two days ago |
| Location | Bladder and urethra |
| Character | Burning, urgency, cloudy strong-smelling urine, on top of mild radiation frequency |
| Severity | Discomfort 4 of 10 |
| Context | Third week of pelvic radiation; third weekly cisplatin four days ago |
| Associated signs and symptoms | No fever, flank pain, vomiting, or blood in the urine |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Tired; no fever or chills |
| Gastrointestinal | Positive | Loose stools twice daily on loperamide; nausea controlled; no abdominal pain |
| Genitourinary | Positive | Burning, urgency, cloudy urine; vaginal bleeding nearly stopped; no flank pain or blood in the urine |
| Psychiatric | Negative | Coping; no thoughts of self-harm |
4 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairy | One tablet by mouth once daily | Oral route | 2026-02-09 to 2026-08-17 | completed | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day | One or two tablets every 6 hours when needed, no more than 6 a day | Oral route | 2026-02-09 | active | S |
| Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days | One capsule twice daily with food for 5 days | Oral route | 2026-03-27 to 2026-03-31 | completed | S |
| Cisplatin 40 mg/m2 (64 mg) intravenous infusion once weekly for five weeks during pelvic radiation, with hydration and antiemetic premedication in the infusion center | 64 mg intravenously once weekly for five doses | Intravenous route | 2026-03-09 to 2026-04-06 | completed | S |
| Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours when needed for nausea in the days after cisplatin | One tablet every 8 hours when needed for nausea | Oral route | 2026-03-09 to 2026-04-10 | completed | S |
| Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than 8 a day | Two capsules after the first loose stool, then one after each, no more than 8 a day | Oral route | 2026-03-09 to 2026-05-04 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-03-27 | Body height | 165 | cm | S |
| 2026-03-27 | Body weight | 51.4 | kg | S |
| 2026-03-27 | Body mass index (BMI) [Ratio] | 18.9 | kg/m2 | S |
| 2026-03-27 | Systolic blood pressure | 106 | mm[Hg] | S |
| 2026-03-27 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-03-27 | Heart rate | 88 | /min | S |
| 2026-03-27 | Respiratory rate | 16 | /min | S |
| 2026-03-27 | Body temperature | 37.2 | Cel | S |
| 2026-03-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-03-27 | Leukocytes [#/volume] in Blood by Automated count | 4.1 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-03-27 | Neutrophils [#/volume] in Blood by Automated count | 2.6 | 10*3/uL | 1.5-7.5 10*3/uL | Normal | S |
| 2026-03-27 | Hemoglobin [Mass/volume] in Blood | 10.4 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-03-27 | Platelets [#/volume] in Blood by Automated count | 168 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-27 | Creatinine [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 2026-03-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 101 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
Physical Exam
Vital signs recorded on 2026-03-27; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Tired but comfortable; temperature 37.2 °C, pulse 88, blood pressure 106/66 |
| Abdomen | Soft; mild suprapubic tenderness; no other tenderness |
| Back | No costovertebral angle tenderness |
| Skin | Mild redness of the skin in the radiation field; no breakdown |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation booked | resolved | confirmed |
N93.8 | S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation. |
| Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairs | active | confirmed |
D50.0 | S — Synthetic modern finding linked to her documented anemia from vaginal bleeding. |
| Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 2018 staging. Synthetic modern episode linked to her documented cervical cancer | active | confirmed |
C53.9 | S — Synthetic modern diagnosis made at the gynecologic oncology consultation. |
| Acute cystitis during pelvic chemoradiation: two days of new burning, urgency and cloudy urine on top of mild radiation frequency, without fever or flank pain; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; neutrophil count and kidney function normal; resolved | active | confirmed |
N30.00 | S — Synthetic acute infection; not a historical claim. |
Assessment and Plan
- Acute cystitis during chemoradiation (N30.00). New burning, urgency and cloudy urine with leukocyte esterase and nitrite on the dipstick point to a bladder infection rather than radiation cystitis alone. No fever or flank pain to suggest kidney infection. The neutrophil count is 2.6 x10^3/uL, so she is not neutropenic, and kidney function is normal (creatinine 0.8 mg/dL, eGFR 101), so nitrofurantoin is suitable. A urine culture was sent because radiation can mimic infection and a clear result guides any recurrence. [S]
- Nitrofurantoin 100 mg twice daily with food for 5 days.
- Fluids through the day.
- Same-day call for fever of 38 °C or more, rigors, flank pain, or vomiting, because she is receiving chemotherapy.
- Radiation oncology team informed; treatment continues without a break.
- Culture result by phone.
- Squamous cell carcinoma of the cervix, FIGO 2018 stage IIB (C53.9). On schedule: week three of radiation, three of five cisplatin doses. Blood count adequate for the next dose (hemoglobin 10.4 g/dL, platelets 168). Diarrhea grade 1 on loperamide; nausea controlled. [S]
- Continue chemoradiation as planned.
- Continue loperamide and ondansetron as needed.
- Iron deficiency anemia (D50.0). Hemoglobin 10.4 g/dL, holding above 10 during radiation. [S]
- Continue ferrous sulfate.
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026); International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (2010)
Follow-up: Culture result by phone. Weekly on-treatment review with the oncology team; review here two weeks after brachytherapy. Next scheduled visit 2026-05-18: review two weeks after completing chemoradiation and brachytherapy: side effects, menopause symptoms, and survivorship care. [S]